Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab

Primary liver cancer is characterized by closely related with chronic liver inflammation, thereby reversing hypoxic immunosuppressive microenvironment of tumor cell growth by immunotherapy drug is a potentially effective strategy. Camrelizumab is an anti-PD-1 antibody being developed by Jiangsu Heng...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Wenling, Cai, Lihong, Zhang, Minjie, Wu, Yali, Sun, Huina, Wang, Yan-Dong, Xia, Yubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413100/
https://www.ncbi.nlm.nih.gov/pubmed/37575222
http://dx.doi.org/10.3389/fimmu.2023.1221418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413100/
https://www.ncbi.nlm.nih.gov/pubmed/37575222
http://dx.doi.org/10.3389/fimmu.2023.1221418

Ejemplares similares